Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Table 3 Smoking-associated risk of end-stage renal failure (stratified for ACE inhibitor treatment and adjusted for systolic blood pressure) in 144 male patients with IgA-glomerulonephritis or autosomal dominant polycystic kidney disease [61]

From: Cigarette smoking: an important renal risk factor – far beyond carcinogenesis

Pack-years Odds ratio ACE inhibitor 95%-confidence intervall p-value* Odds ratio No ACE inhibitor 95%-confidence intervall p-value*
<5 1.0 - - 1.0 - -
>5 1.4 0.3–7.1 0.65 10.1 2.3–45 0.002
  1. * Wald χ2.